13 August 2024
Non-Pharmacological Interventions Poised to Play a Greater Role in the Treatment of Individuals with Parkinson's Disease, Experts Say
Amsterdam, the Netherlands – The field of non-pharmacological interventions for the treatment of individuals with Parkinson's disease (PD) is reaching maturity and has the potential to substantially improve patient care in the future.
22 July 2024
Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics
Amsterdam, the Netherlands – To date Parkinson's disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an objective, quantifiable biomarker for the diagnosis of this highly prevalent movement disorder.
11 April 2024
On World Parkinson’s Day, a New Theory Emerges on the Disease’s Origins and Spread
Amsterdam, the Netherlands – The nose or the gut? For the past two decades, the scientific community has debated the wellspring of the toxic proteins at the source of Parkinson’s disease.
25 January 2024
People with Parkinson’s benefit from new Home Based Care pathway, study shows
A pioneering care programme through which people with Parkinson’s are supported in managing and monitoring their condition at home has been shown to have benefits for patients and care teams, according to a new study.
19 December 2023
Advancements in Parkinson's Disease Research: The Winners of the 2023 Parkinson Prize
The Journal of Parkinson’s Disease is proud to announce the two articles that have won this year’s Parkinson Prize, recognizing these outstanding contributions to the advancement to Parkinson’s disease (PD) research. Recipients of the award are co-authors Kathrin Brockmann, MD, (Center of Neurology at the University of Tübingen, Germany) and Milan Zimmermann, MD (University Hospital of Tuebingen, Germany) for best basic research article, and Dareia S. Roos, MD, (Amsterdam University Medical Center, The Netherlands) for best clinical research article.
6 December 2023
Scientists Plead to Be Heard in Pesticide Debate: Exposure Linked to Risk of Developing Parkinson´s Disease Via Changes in Gut Microbiome
Amsterdam, the Netherlands – While the European Union has just renewed the approval of the use of herbicide glyphosate for another ten years, scientists issue a call to action to reduce or replace the use of agrochemicals.
9 November 2023
Sage Grows Research Portfolio by Acquiring IOS Press
Los Angeles, USA – Global independent academic publisher Sage has acquired IOS Press, an independent publisher founded in Amsterdam in 1987 that specializes in health, life, and computer sciences.
21 June 2023
Journal of Parkinson's Disease (JPD) Included in the Directory of Open Access Journals (DOAJ)
Amsterdam, The Netherlands - Editors-in-Chief Bas Bloem, MD, PhD, and Lorraine Kalia, MD, PhD, proudly announce Journal of Parkinson's Disease (JPD) has been accepted into the Directory of Open Access Journals (DOAJ). Being included in the DOAJ is a significant milestone as it means that JPD meets the rigorous standards of the DOAJ's evaluation process, which assesses the quality, openness, and transparency of open access journals.
23 March 2023
Adding Hope to the Therapeutic Mix Can Empower Persons with Parkinson's Disease
Healthcare professionals recommend adding “hopamine” as a prerequisite for personalized medicine. Based on the personal experiences of Marina Noordegraaf, a commentary published in the Journal of Parkinson’s Disease, proposes that adding “hopamine” to the therapeutic mix can contribute to the empowerment of persons with Parkinson's disease.
Pages
